China biosynthesis start-up Bluepha raises $58m
Bluepha, a Chinese start-up focused on bio-based chemicals, has raised CNY 400m (USD 58m) in a fourth tranche of Series B funding.
The round was led by Beijing-based Zhong Ping Capital with participation from state-owned Jiangsu Huanghai Financial Holding Group. The company has also secured a CNY 500m credit line from SPD Silicon...
More on Greater China
Latest News
Singapore's Qualgro seeks $150m for Fund III
Qualgro Partners, a Singapore-headquartered venture capital firm, is looking to raise USD 150m for its third fund.
PE-backed CompareAsiaGroup merges with US-listed SPAC
CompareAsiaGroup, an Asia-focused financial products comparison platform also known as MoneyHero Group, has agreed to merge with a US-listed special purpose acquisition company (SPAC) at an enterprise value of approximately USD 342m.
VC investors primed for exit with China Youzan reorganisation
Hillhouse Capital and Matrix Partners China are set for liquidity events after China Youzan, an e-commerce software-as-a-service (SaaS) business listed in Hong Kong, agreed to take full control of its key subsidiary for HKD 2.6bn (USD 334.5m).
Goldman backs Japan taxi-hailing player Go
Goldman Sachs Asset Management (GSAM) has committed JPY 10bn (USD 75m) in Series D funding to Go Inc, operator of a Japan-based taxi-hailing app.